Related Experiment Video
Updated: Jul 14, 2026

08:40
Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Salmonella-induced enteritis: molecular pathogenesis and therapeutic implications
Abigail N Layton1, Edouard E Galyov
1Institute for Animal Health, Compton, Newbury, Berkshire, RG20 7NN, UK. abigail.layton@bbsrc.ac.uk
Expert Reviews in Molecular Medicine
|July 4, 2007
Summary
Salmonella enteritis causes significant economic losses. Understanding its molecular mechanisms, involving bacterial type III secretion systems and host factors like Toll-like receptors, is key to developing new therapeutics due to rising antibiotic resistance.
Area of Science:
- Microbiology
- Immunology
- Gastroenterology
Background:
- Salmonella enteritis poses global economic and welfare challenges.
- Severe systemic infections occur in vulnerable populations (immunocompromised, young, elderly).
- Antibiotic resistance and lack of vaccines necessitate alternative therapeutic strategies.
Purpose of the Study:
- To review the molecular mechanisms of Salmonella-induced enteritis.
- To explore bacterial and host factors contributing to disease pathogenesis.
- To discuss the impact of mechanistic understanding on therapeutic development.
Main Methods:
- Review of scientific literature on Salmonella enteritis.
- Analysis of bacterial virulence factors, including type III secretion systems (T3SS).
- Examination of host immune responses, focusing on Toll-like receptors (TLRs) and cytokines.
- Discussion of animal and cell culture models for studying Salmonella enteritis.
Main Results:
- T3SS inject bacterial proteins into host cells, triggering responses that promote enteritis.
- Host cytokines, while part of defense, can exacerbate Salmonella-induced enteritis with bacterial factors.
- Understanding molecular interactions is crucial for identifying therapeutic targets.
Conclusions:
- Elucidating Salmonella's molecular pathogenesis is vital for combating antibiotic-resistant strains.
- Targeting bacterial factors and host responses offers promising avenues for novel therapeutics.
- Continued research into disease mechanisms will drive the development of effective treatments for Salmonella enteritis.
Related Concept Videos
Bacterial Gastroenteritis
Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Amebiasis
Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Fungal Phylum Microsporidia
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...

